Anti-inflammatory effect of recreational exercise in TNBS-Induced colitis in rats: Role of NOS/HO/MPO system

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Szalai, Zita ^a   Szász, András ^b,c   Nagy, István ^c   Puskás, László G ^c,d   Kupai, Krisztina ^a   Király, Adél ^a   Berkó, Anikó Magyariné ^a   Pósa, Anikó ^a   Strifler, Gerda ^c   Baráth, Zoltán ^b   Nagy, Lajos I ^d   Szabó, Renáta ^a   Pávó, Imre ^a   Murlasits, Zsolt ^e   Gyöngyösi, Mariann ^f   Varga, Csaba ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d AVIDIN LTD   (Hungary)

^e UNIVERSITY OF PHYSICAL EDUCATION   (Hungary)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY EFFECTS; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY MEDIATORS; NITRIC-OXIDE SYNTHASE; PHYSICAL EXERCISE; PROTECTIVE EFFECTS; TRINITROBENZENE SULPHONIC ACIDS;

DISEASES; ENZYME ACTIVITY; NITRIC OXIDE; SPORTS; WHEELS;

GENE EXPRESSION;

AUTACOID; CXCL1 CHEMOKINE; HEME OXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; ISOENZYME; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLON; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; EXPERIMENTAL COLITIS; GENE EXPRESSION; KINESIOTHERAPY; MALE; NONHUMAN; PHYSICAL ACTIVITY; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; RECREATIONAL THERAPY; RUNNING; SEDENTARY LIFESTYLE; TREATMENT DURATION; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; COLITIS; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION PROFILING; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; COLITIS; COLON; GENE EXPRESSION PROFILING; HEME OXYGENASE (DECYCLIZING); INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; MALE; NITRIC OXIDE SYNTHASE; PEROXIDASE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896818202     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/925981     Document Type: Article

References (41)

1. van Wijck K., Lenaerts K., Grootjans J., Wijnands K. A., Poeze M., van Loon L. J., Dejong C. H., Buurman W. A., Physiology and pathophysiology of splanchnic hypoperfusion and intestinal injury during exercise: strategies for evaluation and prevention. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2012 303 3 G155 G168 10.1152/ajpgi.00066.2012
2. Narula N., Fedorak R. N., Exercise and inflammatory bowel disease. The Canadian Journal of Gastroenterology 2008 22 5 497 504 2-s2.0-46749118826
3. Peters H. P. F., de Vries W. R., Vanberge-Henegouwen G. P., Akkermans L. M. A., Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut 2001 48 3 435 439 2-s2.0-0035062165 10.1136/gut.48.3.435
4. Huibregtse I. L., van Lent A. U., van Deventer S. J. H., Immunopathogenesis of IBD: insufficient suppressor function in the gut? Gut 2007 56 4 584 592 2-s2.0-34147196190 10.1136/gut.2006.103523
5. Khor B., Gardet A., Xavier R. J., Genetics and pathogenesis of inflammatory bowel disease. Nature 2011 474 7351 307 317 2-s2.0-79959216005 10.1038/nature10209
6. Arijs I., de Hertogh G., Machiels K., van Steen K., Lemaire K., Schraenen A., van Lommel L., Quintens R., van Assche G., Vermeire S., Schuit F., Rutgeerts P., Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment. The American Journal of Gastroenterology 2011 106 4 748 761 2-s2.0-79953800521 10.1038/ajg.2011.27
7. Kruidenier L., Kuiper I., Lamers C. B. H. W., Verspaget H. W., Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. The Journal of Pathology 2003 201 1 28 36 2-s2.0-0141626704 10.1002/path.1409
8. Juhasz B., Der P., Szodoray P., Gesztelyi R., Lekli I., Bak I., Antal M., Maulik N., Tosaki A., Vecsernyes M., Adrenocorticotrope hormone fragment (4-10) attenuates the ischemia/reperfusion-induced cardiac injury in isolated rat hearts. Antioxidants and Redox Signaling 2007 9 11 1851 1861 2-s2.0-35448965155 10.1089/ars.2006.1535
9. Juhasz B., Varga B., Czompa A., Bak I., Lekli I., Gesztelyi R., Zsuga J., Kemeny-Beke A., Antal M., Szendrei L., Tosaki A., Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium. Journal of Cellular and Molecular Medicine 2011 15 9 1973 1982 2-s2.0-80052184600 10.1111/j.1582-4934.2010.01153.x
10. Kertesz A., Bombicz M., Priksz D., Balla J., Balla G., Gesztelyi R., Varga B., Haines D. D., Tosaki A., Juhasz B., Adverse impact of diet-induced hypercholesterolemia on cardiovascular tissue homeostasis in a rabbit model: time-dependent changes in cardiac parameters. International Journal of Molecular Sciences 2013 14 9 19086 19108 10.3390/ijms140919086
11. Abraham N. G., Kappas A., Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews 2008 60 1 79 127 2-s2.0-46949108047 10.1124/pr.107.07104
12. Soares M. P., Bach F. H., Heme oxygenase-1: from biology to therapeutic potential. Trends in Molecular Medicine 2009 15 2 50 58 2-s2.0-60649095328 10.1016/j.molmed.2008.12.004
13. Varga C., Laszlo F., Fritz P., Cavicchi M., Lamarque D., Horvath K., Posa A., Berko A., Whittle B. J. R., Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat. The European Journal of Pharmacology 2007 561 1-3 164 171 2-s2.0-33947248022 10.1016/j.ejphar.2006.12.022
14. Horváth K., Varga C., Berkó A., Pósa A., László F., Whittle B. J. R., The involvement of heme oxygenase-1 activity in the therapeutic actions of 5-aminosalicylic acid in rat colitis. The European Journal of Pharmacology 2008 581 3 315 323 2-s2.0-38949193198 10.1016/j.ejphar.2007.12.004
15. Adamopoulos S., Parissis J., Karatzas D., Kroupis C., Georgiadis M., Karavolias G., Paraskevaidis J., Koniavitou K., Coats A. J. S., Kremastinos D. T., Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. Journal of the American College of Cardiology 2002 39 4 653 663 2-s2.0-0037138585 10.1016/S0735-1097(01)01795-8
16. +/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium. Free Radical Biology and Medicine 2007 42 10 1487 1495 2-s2.0-34247135353 10.1016/j.freeradbiomed.2007.02.011
17. Kolios G., Valatas V., Ward S. G., Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004 113 4 427 437 2-s2.0-9944233058 10.1111/j.1365-2567.2004.01984.x
18. Porras M., Martín M. T., Torres R., Vergara P., Cyclical upregulated iNOS and long-term downregulated nNOS are the bases for relapse and quiescent phases in a rat model of IBD. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2006 290 3 G423 G430 2-s2.0-33644989275 10.1152/ajpgi.00323.2005
19. Harpavat M., Keljo D. J., Regueiro M. D., Metabolic bone disease in inflammatory bowel disease. Journal of Clinical Gastroenterology 2004 38 3 218 224 2-s2.0-1242352559 10.1097/00004836-200403000-00005
20. Lee N., Radford-Smith G., Taaffe D. R., Bone loss in Crohn's disease: exercise as a potential countermeasure. Inflammatory Bowel Diseases 2005 11 12 1108 1118 2-s2.0-27944453906 10.1097/01.MIB.0000192325.28168.08
21. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L., Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989 96 3 795 803 2-s2.0-0024552818
22. Bradley P. P., Priebat D. A., Christensen R. D., Rothstein G., Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 1982 78 3 206 209 2-s2.0-0020051148 10.1111/1523-1747.ep12506462
23. Tenhunen R., Marver H. S., Schmid R., The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proceedings of the National Academy of Sciences of the United States of America 1968 61 2 748 755 2-s2.0-0014348401 10.1073/pnas.61.2.748
24. Boughton-Smith N. K., Evans S. M., Laszlo F., Whittle B. J. R., Moncada S., The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. The British Journal of Pharmacology 1993 110 3 1189 1195 2-s2.0-0027133613 10.1111/j.1476-5381.1993.tb13940.x
25. Tong H. H., Chen Y., Liu X., DeMaria T. F., Differential expression of cytokine genes and iNOS induced by nonviable nontypeable Haemophilus influenzae or its LOS mutants during acute otitis media in the rat. International Journal of Pediatric Otorhinolaryngology 2008 72 8 1183 1191 2-s2.0-46049100974 10.1016/j.ijporl.2008.04.007
26. Shi X.-Z., Winston J. H., Sarna S. K., Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2011 300 1 G41 G51 2-s2.0-78650798979 10.1152/ajpgi.00358.2010
27. Xavier R. J., Podolsky D. K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007 448 7152 427 434 2-s2.0-34547176642 10.1038/nature06005
28. Ghosh S., Golbidi S., Werner I., Verchere B. C., Laher I., Selecting exercise regimens and strains to modify obesity and diabetes in rodents: an overview. Clinical Science 2010 119 2 57 74 2-s2.0-77954911083 10.1042/CS20090389
29. Saxena A., Fletcher E., Larsen B., Baliga M. S., Durstine J. L., Fayad R., Effect of exercise on chemically-induced colitis in adiponectin deficient mice. Journal of Inflammation 2012 9 1, article 30 10.1186/1476-9255-9-30
30. Mekinian A., Tamouza R., Pavy S., Gestermann N., Ittah M., Mariette X., Miceli-Richard C., Functional study of TNF- α promoter polymorphisms: literature review and meta-analysis. The European Cytokine Network 2011 22 2 88 102 2-s2.0-79961009652 10.1684/ecn.2011.0285
31. Powers S. K., Jackson M. J., Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiological Reviews 2008 88 4 1243 1276 2-s2.0-55949118714 10.1152/physrev.00031.2007
32. Brooks S. V., Vasilaki A., Larkin L. M., McArdle A., Jackson M. J., Repeated bouts of aerobic exercise lead to reductions in skeletal muscle free radical generation and nuclear factor B activation. The Journal of Physiology 2008 586 16 3979 3990 2-s2.0-50049091026 10.1113/jphysiol.2008.155382
33. George L., Lokhandwala M. F., Asghar M., Exercise activates redox-sensitive transcription factors and restores renal D1 receptor function in old rats. The American Journal of Physiology-Renal Physiology 2009 297 5 F1174 F1180 2-s2.0-70350738494 10.1152/ajprenal.00397.2009
34. Kasimay Ö., Güzel E., Gemici A., Abdyli A., Sulovari A., Ercan F., Yěen B. Ç., Colitis-induced oxidative damage of the colon and skeletal muscle is ameliorated by regular exercise in rats: the anxiolytic role of exercise. Experimental Physiology 2006 91 5 897 906 2-s2.0-33747621612 10.1113/expphysiol.2006.034439
35. Sasaki M., Bharwani S., Jordan P., Elrod J. W., Grisham M. B., Jackson T. H., Lefer D. J., Alexander J. S., Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radical Biology and Medicine 2003 35 12 1679 1687 2-s2.0-0346996626 10.1016/j.freeradbiomed.2003.09.016
36. Aoi W., Naito Y., Takagi T., Kokura S., Mizushima K., Takanami Y., Kawai Y., Tanimura Y., Hung L. P., Koyama R., Ichikawa H., Yoshikawa T., Regular exercise reduces colon tumorigenesis associated with suppression of iNOS. Biochemical and Biophysical Research Communications 2010 399 1 14 19 2-s2.0-77955571892 10.1016/j.bbrc.2010.07.023
37. - cells. Journal of Applied Physiology 2011 111 3 929 937 2-s2.0-80053036133 10.1152/japplphysiol.00541.2011
38. Zwolinska-Wcislo M., Brzozowski T., Ptak-Belowska A., Targosz A., Urbanczyk K., Kwiecien S., Sliwowski Z., Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World Journal of Gastroenterology 2011 17 36 4076 4089 2-s2.0-80155161341 10.3748/wjg.v17.i36. 4076
39. Dou W., Zhang J., Sun A., Zhang E., Ding L., Mukherjee S., Wei X., Chou G., Wang Z. T., Mani S., Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF- B signalling. The British Journal of Nutrition 2013 110 4 599 608 10.1017/S0007114512005594
40. Xing J., You C., Dong K., Sun J., You H., Dong Y., Sun J., Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats. International Immunopharmacology 2013 15 3 524 531 10.1016/j.intimp.2013.02.008
41. Sonnenberg A., Age distribution of IBD hospitalization. Inflammatory Bowel Diseases 2010 16 3 452 457 2-s2.0-77149177418 10.1002/ibd.21058